Earlham Institute

Earlham Institute
Name	Earlham Institute
Established	2014
Type	Research institute
Location	Norwich, Norfolk, United Kingdom

Contents

Earlham Institute Earlham Institute is a research centre located in Norwich, Norfolk, United Kingdom focusing on genomics, bioinformatics, and computational biology. It operates within a network that includes UK Research and Innovation, Biotechnology and Biological Sciences Research Council, University of East Anglia, John Innes Centre, and the Norwich Research Park, contributing to projects linked with Wellcome Trust, European Molecular Biology Laboratory, European Bioinformatics Institute, and international consortia such as the 100,000 Genomes Project and the International Wheat Genome Sequencing Consortium. The institute engages with stakeholders including Defra, NERC, Innovate UK, and industry partners like Illumina, Oxford Nanopore Technologies, and GlaxoSmithKline.

History

The institute was founded amid drives in the Biotechnology and Biological Sciences Research Council and regional strategies tied to the Norwich Research Park and the Greater Norwich Development Partnership; its founding phase involved collaborations with the John Innes Centre, Sainsbury Laboratory, University of East Anglia, and funding negotiations with UK Research and Innovation and the Wellcome Trust. Early programmes drew on expertise from projects such as the 100,000 Genomes Project, the Human Genome Project, and the ENCODE Project, and personnel movements included researchers formerly associated with the European Molecular Biology Laboratory, European Bioinformatics Institute, and academic groups from the University of Cambridge and University of Oxford. The institute's development intersected with regional initiatives like the Greater Norwich Development Partnership and national strategies such as the Life Sciences Industrial Strategy.

Research themes include genomics of plant pathogens, crop genomics connected to consortia like the International Wheat Genome Sequencing Consortium and projects funded by Defra and BBSRC, microbial genomics linked to outbreaks studied in contexts such as the H1N1 pandemic, and bioinformatics method development informed by standards from the European Bioinformatics Institute and the National Center for Biotechnology Information. Programmes span applied projects with industry partners such as Illumina and Oxford Nanopore Technologies and academic collaborations with the John Innes Centre, Sainsbury Laboratory, University of East Anglia, EMBL-EBI, and international teams including researchers from the Broad Institute, University of California, Davis, and Wageningen University. The institute contributes pipelines and software interoperable with platforms developed at European Bioinformatics Institute, National Center for Biotechnology Information, and tools used by initiatives like the 1000 Genomes Project.

Facilities include high-throughput sequencing suites compatible with systems from Illumina and Oxford Nanopore Technologies, high-performance computing clusters interoperable with resources at the European Bioinformatics Institute and university supercomputing centres such as those at the University of Cambridge and University of Oxford, and secure data management practices informed by policies from UK Research and Innovation and the Wellcome Trust. Laboratory space supports molecular biology techniques used in projects reminiscent of those at the Sainsbury Laboratory and John Innes Centre, while computational teams liaise with infrastructures like the Cloud Infrastructure for Microbial Bioinformatics and regional research data services associated with Norwich Research Park partners.

The institute maintains partnerships with academic centres including the John Innes Centre, Sainsbury Laboratory, University of East Anglia, University of Cambridge, University of Oxford, and international organisations such as the European Bioinformatics Institute, European Molecular Biology Laboratory, Broad Institute, and Wageningen University. Industry collaborations have included projects with Illumina, Oxford Nanopore Technologies, GlaxoSmithKline, and agri-tech companies linked to the Agri-Tech East network. Research consortia and public-sector partners have involved Defra, BBSRC, Wellcome Trust, and participation in large-scale efforts like the 100,000 Genomes Project and plant genomics initiatives such as the International Wheat Genome Sequencing Consortium.

Funding streams derive from national funders such as the Biotechnology and Biological Sciences Research Council, UK Research and Innovation, project awards from the Wellcome Trust, competitive grants tied to European Research Council precedents, and collaborative contracts with industry partners including Illumina and GlaxoSmithKline. Governance arrangements align with oversight expectations similar to those at the John Innes Centre and involve strategic partnerships with the Norwich Research Park governance structures and academic stakeholders from the University of East Anglia and regional development bodies like the Greater Norwich Development Partnership.

Training programmes, postgraduate supervision, and short courses are delivered in cooperation with the University of East Anglia, John Innes Centre, Sainsbury Laboratory, and international training hubs such as EMBL-EBI and the Broad Institute. Public engagement activities mirror outreach models used by the John Innes Centre and Sainsbury Laboratory, participating in regional events associated with the Norwich Research Park and national initiatives from the Wellcome Trust and UK Research and Innovation to communicate genomics, bioinformatics, and agricultural science to diverse audiences.